mEphA4-Fc

N/A

Report date: 2024/02/06 16:32:28

Base Information

Drug NamemEphA4-Fc
Drug Alias NamemEphA4-Fc
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionErythropoietin-producing hepatocellular receptor A4 blockers
TargetsErythropoietin-producing hepatocellular receptor A4
Therapy Area/IndicationsNerve DegenerationAmyotrophic Lateral SclerosisNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesQueensland Brain Institute
China Registration ClassN/A

Develop Information

Active CompaniesNuNerve Pty Ltd
Inactive CompaniesN/A
Active IndicationsNerve DegenerationAmyotrophic Lateral Sclerosis
Inactive IndicationsNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A